United Therapeutics (UTHR) PT Lifted to $195 at Wedbush Posts Q4
Tweet Send to a Friend
Wedbush analyst Liana Moussatos reiterated an Outperform rating and boosted her price target on United Therapeutics Corp. (NASDAQ: UTHR) to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE